These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15557524)
1. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Maramattom BV; Wijdicks EF Neurology; 2004 Nov; 63(10):1958-9. PubMed ID: 15557524 [TBL] [Abstract][Full Text] [Related]
10. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens. DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069 [TBL] [Abstract][Full Text] [Related]
11. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens. Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522 [TBL] [Abstract][Full Text] [Related]
13. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403 [TBL] [Abstract][Full Text] [Related]
14. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol. Jaber JJ; Feustel PJ; Elbahloul O; Conti AD; Gallichio MH; Conti DJ Clin Transplant; 2007; 21(1):101-9. PubMed ID: 17302598 [TBL] [Abstract][Full Text] [Related]
15. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781 [TBL] [Abstract][Full Text] [Related]
16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
17. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens. Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391 [TBL] [Abstract][Full Text] [Related]
18. Combined sirolimus-calcineurin inhibitor immunosuppressive therapy in simultaneous heart and kidney transplantation: a retrospective analysis of a single hospital's experience. Hsu KH; Chou NK; Tsai MK; Chi NH; Chen YS; Yu HY; Wang CH; Ko WJ; Tsao CI; Lee PH; Wang SS Transplant Proc; 2010 Apr; 42(3):934-7. PubMed ID: 20430208 [TBL] [Abstract][Full Text] [Related]
20. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Chang GJ; Mahanty HD; Quan D; Freise CE; Ascher NL; Roberts JP; Stock PG; Hirose R Liver Transpl; 2000 Nov; 6(6):734-40. PubMed ID: 11084060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]